NIT-OCCLUD PDA

Occluder, Patent Ductus, Arteriosus

FDA Premarket Approval P120009

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the nit-occlud® pda. This device is a permanently implanted prosthesis indicated for percutaneous, transcatheter closure of small to moderate size patent ductus arteriosus with a minimumangiographic diameter less than 4 mm.

DeviceNIT-OCCLUD PDA
Classification NameOccluder, Patent Ductus, Arteriosus
Generic NameOccluder, Patent Ductus, Arteriosus
ApplicantPFM MEDICAL, INC
Date Received2012-05-04
Decision Date2013-08-16
Notice Date2013-08-26
PMAP120009
SupplementS
Product CodeMAE
Docket Number13M-0988
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address PFM MEDICAL, INC 1916 Palomar Oaks Way suite 150 carlsbad, CA 92008
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P120009Original Filing
S003 2016-10-12 Normal 180 Day Track No User Fee
S002 2014-12-10 30-day Notice
S001 2014-05-05 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
4042301160027 P120009 000
04042301159939 P120009 000
4042301160041 P120009 003
4042301160003 P120009 003
4042301159984 P120009 003
4042301159960 P120009 003

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.